| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Revenue | $135.6M | +8.9% |
| Cost of Revenue | $83.0M | +14.0% |
| Gross Profit | $52.6M | +1.7% |
| R&D Expense | $16.3M | +2.4% |
| SG&A Expense | $26.6M | +2.3% |
| Operating Income | $7.1M | -37.2% |
| Interest Expense | $187K | +39.6% |
| Pre-tax Income | -$6.5M | -151.4% |
| Income Tax | $114K |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.9M | -63.3% |
| Short-term Investments | $30.2M | +102.6% |
| Accounts Receivable | $14.6M | -27.4% |
| Inventory | $26.2M | +42.3% |
| Current Assets | $89.4M | +17.9% |
| Total Assets | $152.2M | -0.6% |
| Current Liabilities | $17.2M | -13.1% |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.1M | -158.4% |
| Capital Expenditures | $3.9M | -2.7% |
| Investing Cash Flow | $3.8M | +132.2% |
| Financing Cash Flow | -$6.4M | -1116.2% |
| Free Cash Flow | -$12.9M | -211.6% |
| -68.6% |
| Net Income | -$6.6M | -153.9% |
| EPS (Basic) | -$0.50 | -153.8% |
| EPS (Diluted) | -$0.50 | -154.3% |
| Long-term Debt |
| $0 |
| — |
| Total Liabilities | $17.6M | -13.6% |
| Stockholders' Equity | $134.6M | +1.4% |